1. AF.47 HOSPITALIZATION FOR DRUG INFUSION DOES NOT INCREASE COVID INFECTION RATE, IBD RELAPSES DUE TO INFECTIONS AND LEVELS OF ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY. (September 2021) Authors: Bertani, L.; Barberio, B.; Tricò, D.; Zanzi, F.; Maniero, D.; Ceccarelli, L.; Marsilio, I.; Minciotti, M.; Coppini, F.; Lorenzon, G.; Mumolo, M.G.; Zingone, F.; Costa, F.; Savarino, E.V. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (September 2021) Authors: Marsilio, I.; Maniero, D.; Lorenzon, G.; Rigo, A.; Cardin, R.; Facchin, S.; Barberio, B.; D'Incà, R.; Zingone, F.; Bahur, B.; Bray, K.; Savarino, E. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.56 COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. (September 2021) Authors: Maniero, D.; Lorenzon, G.; Marsilio, I.; Rigo, A.; Cardin, R.; Facchin, S.; Barberio, B.; D'Incà, R.; Zingone, F.; Bahur, B.; Bray, K.; Savarino, E.V. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter: oesophageal histological abnormalities and GERD ‐ an underestimated relationship requiring more attention. Issue 1 (11th December 2017) Authors: Savarino, E.; Lorenzon, G.; Facchin, S.; Savarino, V. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 1(2018) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.05.1 IDENTIFICATION OF MARKERS OF OXIDATIVE STRESS IN CELIAC DISEASE. (September 2021) Authors: Marsilio, I.; Cardin, R.; Maniero, D.; Lorenzon, G.; Scaramuzza, G.; Savarino, E.V.; Farinati, F.; Zingone, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.06.6 COMPARATIVE ASSESSMENT C-REACTIVE PROTEIN BETWEEN A POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (IMMUNONEPHELOMETRIC TESTING). (September 2021) Authors: Lorenzon, G.; Marsilio, I.; Maniero, D.; Rigo, A.; Barberio, B.; Zingone, F.; Bahur, B.; Bray, K.; Savarino, E.V. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH. (25th March 2019) Authors: Buda, A.; Facchin, S.; Lorenzon, G.; Barberio, B.; Zingone, F.; Savarino, E.; D'Incà, R. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.16.5 IMPACT OF ADALIMUMAB'S PATIENT SUPPORT PROGRAM ON ADHERENCE TO ANTI-TNF-ALFA THERAPY IN INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER ANALYSIS. Issue 2 (15th March 2018) Authors: Lorenzon, G.; Savarino, E.; Rigo, A.; Caccaro, R.; Girardin, G.; Barberio, B.; Sturniolo, G.C.; Zingone, F.; Facchin, S.; Marinelli, C.; Inferrera, M.; D'Incà, R. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P.02.10 REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD). Issue 2 (15th March 2018) Authors: Pugliese, D.; Rogai, F.; Variola, A.; Viola, A.; Privitera, A.C.; Allocca, M.; Bossa, F.; Cappello, M.; Lorenzon, G.; Mazzuoli, S.; Principi, M.B.; Sablich, R.; Ferronato, A.; Festa, S.; Moser, L.; Tapete, G.; Bodini, G.; Di Girolamo, M.; Grossi, L.; Mocci, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P.02.12 MICROBIOTA PROFILE AND DYSBIOSIS ASSESSMENT IN CLINICAL PRACTICE: A PILOT STUDY ON IBD PATIENTS. Issue 2 (15th March 2018) Authors: Facchin, S.; Buda, A.; Perini, B.; Sturniolo, G.C.; D'Incà, R.; Lorenzon, G.; Savarino, E. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗